- Home
- PBA vs ZTS Comparison
PBA vs ZTS Comparison
Compare PBA & ZTS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PBA | ZTS |
|---|---|---|
| Founded | 1997 | 1952 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Oil & Gas Production | Biotechnology: Pharmaceutical Preparations |
| Sector | Energy | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 28.0B | 33.5B |
| IPO Year | 2012 | 2012 |
Fundamental Metrics
Financial Performance| Metric | PBA | ZTS |
|---|---|---|
| Price | $50.23 | $83.62 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 16 |
| Target Price | $48.51 | ★ $89.69 |
| AVG Volume (30 Days) | 686.3K | ★ 4.1M |
| Earning Date | 11-05-2026 | 11-05-2026 |
| Dividend Yield | ★ 4.18% | 2.56% |
| EPS Growth | N/A | ★ 10.05 |
| EPS | N/A | ★ 4.51 |
| Revenue | N/A | ★ $9,467,000,000.00 |
| Revenue This Year | $11.22 | N/A |
| Revenue Next Year | $5.71 | $0.54 |
| P/E Ratio | $21.43 | ★ $18.38 |
| Revenue Growth | N/A | ★ 2.28 |
| 52 Week Low | $36.20 | $68.92 |
| 52 Week High | $51.58 | $132.49 |
Technical Indicators
Market Signals| Indicator | PBA | ZTS |
|---|---|---|
| Relative Strength Index (RSI) | 57.55 | 58.55 |
| Support Level | $47.16 | $71.78 |
| Resistance Level | $51.39 | $89.29 |
| Average True Range (ATR) | 0.98 | 2.63 |
| MACD | -0.05 | -0.08 |
| Stochastic Oscillator | 69.47 | 54.49 |
Price Performance
Historical ComparisonAbout PBA Pembina Pipeline Corp. (Canada)
Pembina Pipeline is a midstream company serving the Canadian and North American (primarily Bakken) markets with an integrated product portfolio. Its operations include transmission pipelines, oil and gas gathering, fractionation, storage, and natural gas liquid exports. It also has a joint venture through the Cedar LNG export terminal.
About ZTS Zoetis Inc.
Zoetis sells anti-infectives, vaccines, parasiticides, diagnostics, and other health products for animals. The firm earns roughly 30% of total revenue from production animals (cattle, pigs, poultry, and so on) and nearly 70% from companion animal (dogs, horses, cats) products. Its US business is skewed even more heavily toward companion animals, while its international business is slightly skewed toward production animals. The firm has the largest market share in the industry and was previously Pfizer's animal health unit.